Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation

Immune checkpoint inhibitors (ICIs) have been applied to clinical practice and achieved significant therapeutic benefit in a variety of human malignancies. These drugs not only enhance the body’s antitumor immune response but also produce side effects called immune-related adverse events (irAEs). Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shicong, Fu, Yang, Zhu, Bo, Zhang, Bicheng, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518129/
https://www.ncbi.nlm.nih.gov/pubmed/33042827
http://dx.doi.org/10.3389/fonc.2020.01785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518129/
https://www.ncbi.nlm.nih.gov/pubmed/33042827
http://dx.doi.org/10.3389/fonc.2020.01785

Ejemplares similares